Cargando…
NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells
Simvastatin and lovastatin are statins traditionally used for lowering serum cholesterol levels. However, there exists evidence indicating their potential chemotherapeutic characteristics in cancer. In this study, we used bioinformatic analysis of publicly available data in order to systematically i...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070731/ https://www.ncbi.nlm.nih.gov/pubmed/21483694 http://dx.doi.org/10.1371/journal.pone.0018306 |
_version_ | 1782201414757384192 |
---|---|
author | Savas, Sevtap Azorsa, David O. Jarjanazi, Hamdi Ibrahim-Zada, Irada Gonzales, Irma M. Arora, Shilpi Henderson, Meredith C. Choi, Yun Hee Briollais, Laurent Ozcelik, Hilmi Tuzmen, Sukru |
author_facet | Savas, Sevtap Azorsa, David O. Jarjanazi, Hamdi Ibrahim-Zada, Irada Gonzales, Irma M. Arora, Shilpi Henderson, Meredith C. Choi, Yun Hee Briollais, Laurent Ozcelik, Hilmi Tuzmen, Sukru |
author_sort | Savas, Sevtap |
collection | PubMed |
description | Simvastatin and lovastatin are statins traditionally used for lowering serum cholesterol levels. However, there exists evidence indicating their potential chemotherapeutic characteristics in cancer. In this study, we used bioinformatic analysis of publicly available data in order to systematically identify the genes involved in resistance to cytotoxic effects of these two drugs in the NCI60 cell line panel. We used the pharmacological data available for all the NCI60 cell lines to classify simvastatin or lovastatin resistant and sensitive cell lines, respectively. Next, we performed whole-genome single marker case-control association tests for the lovastatin and simvastatin resistant and sensitive cells using their publicly available Affymetrix 125K SNP genomic data. The results were then evaluated using RNAi methodology. After correction of the p-values for multiple testing using False Discovery Rate, our results identified three genes (NRP1, COL13A1, MRPS31) and six genes (EAF2, ANK2, AKAP7, STEAP2, LPIN2, PARVB) associated with resistance to simvastatin and lovastatin, respectively. Functional validation using RNAi confirmed that silencing of EAF2 expression modulated the response of HCT-116 colon cancer cells to both statins. In summary, we have successfully utilized the publicly available data on the NCI60 cell lines to perform whole-genome association studies for simvastatin and lovastatin. Our results indicated genes involved in the cellular response to these statins and siRNA studies confirmed the role of the EAF2 in response to these drugs in HCT-116 colon cancer cells. |
format | Text |
id | pubmed-3070731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30707312011-04-11 NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells Savas, Sevtap Azorsa, David O. Jarjanazi, Hamdi Ibrahim-Zada, Irada Gonzales, Irma M. Arora, Shilpi Henderson, Meredith C. Choi, Yun Hee Briollais, Laurent Ozcelik, Hilmi Tuzmen, Sukru PLoS One Research Article Simvastatin and lovastatin are statins traditionally used for lowering serum cholesterol levels. However, there exists evidence indicating their potential chemotherapeutic characteristics in cancer. In this study, we used bioinformatic analysis of publicly available data in order to systematically identify the genes involved in resistance to cytotoxic effects of these two drugs in the NCI60 cell line panel. We used the pharmacological data available for all the NCI60 cell lines to classify simvastatin or lovastatin resistant and sensitive cell lines, respectively. Next, we performed whole-genome single marker case-control association tests for the lovastatin and simvastatin resistant and sensitive cells using their publicly available Affymetrix 125K SNP genomic data. The results were then evaluated using RNAi methodology. After correction of the p-values for multiple testing using False Discovery Rate, our results identified three genes (NRP1, COL13A1, MRPS31) and six genes (EAF2, ANK2, AKAP7, STEAP2, LPIN2, PARVB) associated with resistance to simvastatin and lovastatin, respectively. Functional validation using RNAi confirmed that silencing of EAF2 expression modulated the response of HCT-116 colon cancer cells to both statins. In summary, we have successfully utilized the publicly available data on the NCI60 cell lines to perform whole-genome association studies for simvastatin and lovastatin. Our results indicated genes involved in the cellular response to these statins and siRNA studies confirmed the role of the EAF2 in response to these drugs in HCT-116 colon cancer cells. Public Library of Science 2011-04-04 /pmc/articles/PMC3070731/ /pubmed/21483694 http://dx.doi.org/10.1371/journal.pone.0018306 Text en Savas et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Savas, Sevtap Azorsa, David O. Jarjanazi, Hamdi Ibrahim-Zada, Irada Gonzales, Irma M. Arora, Shilpi Henderson, Meredith C. Choi, Yun Hee Briollais, Laurent Ozcelik, Hilmi Tuzmen, Sukru NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells |
title | NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells |
title_full | NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells |
title_fullStr | NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells |
title_full_unstemmed | NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells |
title_short | NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells |
title_sort | nci60 cancer cell line panel data and rnai analysis help identify eaf2 as a modulator of simvastatin and lovastatin response in hct-116 cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070731/ https://www.ncbi.nlm.nih.gov/pubmed/21483694 http://dx.doi.org/10.1371/journal.pone.0018306 |
work_keys_str_mv | AT savassevtap nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT azorsadavido nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT jarjanazihamdi nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT ibrahimzadairada nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT gonzalesirmam nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT arorashilpi nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT hendersonmeredithc nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT choiyunhee nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT briollaislaurent nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT ozcelikhilmi nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells AT tuzmensukru nci60cancercelllinepaneldataandrnaianalysishelpidentifyeaf2asamodulatorofsimvastatinandlovastatinresponseinhct116cells |